Creutzfeldt-Jakob disease in humans. The protein only hypothesis claims that the TSE agent were then inoculated to hamsters and their infectious potential investigated up to 545 days postinoculation (PI)(see Table 1 ). Unexpectedly, we achieved successful infection with the DNAse Itreated sample (inoculum 8; see Table 1 ). Two sick animals out of five (40%) -free SAF-derived (inocula 2, 6, 7 and 11) or the controls (inocula 12 and 13) developed scrapie during an observation period of 545 days PI.
we reasoned that recPrP, during β-sheet conversion, could interact specifically with this nucleic acid to form a nucleoprotein complex that would transmit scrapie to recipient animals.
Infectious SAF solution was prepared from 263K-infected hamster brain and exposed to a harsh protein destruction procedure involving phenol-chloroform and PK digestion. The resulting PrP sc -free SAF-derived solution was either used as such or treated with DNAse I (as a control see Supplementary Methods) before it was mixed with various versions of recPrP. The different mixes were then inoculated to hamsters and their infectious potential investigated up to 545 days postinoculation (PI)(see Table 1 ). Unexpectedly, we achieved successful infection with the DNAse Itreated sample (inoculum 8; see Table 1 ). Two sick animals out of five (40%) succumbed to disease with clinical symptoms of scrapie, at 151 and 246 days PI. None of the other animals from either the PrP sc -free SAF-derived (inocula 2, 6, 7 and 11) or the controls (inocula 12 and 13) developed scrapie during an observation period of 545 days PI.
We then characterized the nucleic acid content of our samples, using the Agilent 2100 Bioanalyzer.
To have a more acurate view of the nucleic acids present before and after DNAse I digestion, we examined the parent solution of inoculum 8 (inoculum 2). This inoculum contains the crude nucleic acids extracted from PrP sc preparation. When subjected to DNAse I, we found that inoculum 2 contained two distinct populations of small RNA of sizes averaging ~27 and ~55 nucleotides (Fig.   1a ). This solution showed a complete absence of contaminating or degraded large cellular RNA (Fig. 1b) . By contrast, the DNAse I untreated original solution (inoculum 2) contained a large amount of cellular DNA (heterogenous mixture of sizes <300 nucleotides) masking the small RNA populations (Fig. 1c) . We also investigated the molecular characteristics of inoculum 8. A fraction of the small RNA interacted with the recPrP as shown by its liberation from the protein after PK treatment ( Supplementary Fig. 1a, c) . Moreover, it was sensitive to RNAse A treatment ( Supplementary Fig. 1a , b). Electron microscopy (EM) analysis of the recPrP in the inoculum 8
(subjected to thermal β-sheet conversion) displayed occasional ovoidal and spherical aggregates (diameter ~7-40nm,; Fig. 1d ). These supramolecular structures of recPrP were not observed in the control inoculum 7 containing alpha-recPrP (Fig. 1e) , and no filament-like structures were observed in any of the solutions.
To confirm these first results, we initiated a second experiment (ongoing > 360 days) with new solutions (see Table 1 ). The results up to now appear so convincing that they can be reasonably incorporated in this study. Here, three animals out of nineteen (16%) died of scrapie disease (148, 178 and 207 days PI) after injection with inoculum D which was prepared and treated with DNAse I in the same way as inoculum 8. Again, none of the negative control animals (29 : inocula A, B and C) are showing any clinical signs of scrapie (Table 1) . Inoculum D also contained the two small RNA populations observed in the first experiment ( Supplementary Fig. 1d ).
To verify the animals infected with inoculum 8 died from an authentic scrapie disease, we performed neuropathological and PrP-immunohistochemistry analysis of their brains ( Fig. 2 and Supplementary Fig. 2 ). Results of histopathology revealed spongiosis typical of TSE infection (Fig. 2d,e and Supplementary Fig. 2b ). The spongiosis lesion profile exhibited a much higher score than the 263K profile with particular emphasis on 11 and 9 brain regions (score difference (Sdf) ≥ 1 8 ) in animals 8.1 and 8.2 respectively (Fig. 3a) . The brain of animal 8.1 and 8.2 also showed a more intense PrP staining (Fig. 3b) . In the case of the second experiment, we analyzed one of the infected animals and found a neuropathology and a lesion profile distinct to the 263K strain (supplementary Fig. 4a ).
In the present study, we were able to reveal RNA isolated from scrapie agent, as a factor essential for the acquisition of scrapie infectivity. Our strategy was based on the presumption that artificial and allow the RNA material to associate with recPrP. Therefore, the lack of infectivity on the non DNAse I-treated sample (inoculum 6), can be explained by the inhibitory effect of the DNA (due to its large excess) that most likely hampered the formation of the ribonucleoprotein complex. Unlike the incomplete digestion of cellular DNA from the DNAse I treatment performed during the initial PrP sc purification step, the RNAse A pre-treatment appeared to eliminate all traces of cellular RNA.
This suggested that the highly purified RNA recovered after PK digestion of PrP sc , was protected by this protein during the nuclease digestion. This RNA material of sizes averaging ~27 and ~55 nucleotides, was RNAse A sensitive indicating that it was constituted of single-strand molecules.
Their interaction with recPrP (inoculum 8), was confirmed by their release after PK digestion. The β-sheeted recPrP in inoculum 8 adopted various supramolecular structures of ovoidal and spherical shapes (7-40 nm), not seen in the unconverted recPrP sample (inoculum 7), when observed by EM as previously shown 9 . Such small aggregates of PrP sc would be, according to recent data, the most infectious forms of prions 10 . In future experiments it will be interesting to further dicepher the molecular arrangement between β-sheeted PrP and its ribonucleic partner. A clear understanding of the role played by these intriguing RNA species in the infectious process will only be possible after identification of their sequences (work in progress). One crucial question is whether they are in any way related to recently discovered cellular ribo-regulators designated miRNA, siRNA and piRNA 11, 12 . The possibility of such RNAs interacting with PrP has been evoked previously, but was immediately rejected because of the absence of data establishing a link between the RNA substrate and the infectious phenomenon 13, 14 .
We have created in test tube a macromolecular complex consisting of hamster recPrP and RNA material extracted from 263K prions. The pathogenicity of this novel coupling was validated, after brain inoculation, by the development of neurological disease reflecting typical experimental scrapie in 5/24 (20%) wild-type animals taking into account the two experiments. However on first passage, a remarkable divergence between the infectious β recPrP-RNA complex created in vitro and the natural 263K agent was observed in three tested animals. The lesions obtained with this new infectious entity were clearly more severe, characterized by intense spongiosis, important neuronal loss and gliosis. So the two most important points of our study, namely the absence of residual contamination of our samples and the infectious nature of the in vitro-generated biological entity were observed in both experiments.
It is clear that the infectivity level of our preparations remains modest in that we chose to use minimal conditions essential to ensure the required effect. In future experiments it will be of great interest to explore variables able to improve the infectious nature of these preparations. It will also be important to verify whether our biomacromolecular assemblage, able to generate an infraviral particle, satisfies the virino hypothesis, which dictates that the genome, protected by a coating cellular protein (PrP), is host-independent [15] [16] [17] . The two structural pieces composing the novel infectious entity, β-recPrP and PrP sc -associated RNAs, are by themselves not infectious. It is through their molecular synergy that infectivity manifests. However we cannot exclude the possibility that in exceptional circumstances, RNA alone might be able to initiate the infectious process 4 . Information encoded by the RNA sequences constitute a prerequisite for elucidating the replicative modalities of this new structural version of the scrapie agent. In keeping with the 'paradoxical' prion, it is conceivable that the genetic moiety, as was discovered for PrP, might be host-encoded. Although it can be considered at the rough state, the present work provides serious clues to ultimately resolve in a near future the enigmatic nature of the TSE infectious agent 18 .
Methods summary
Animals and SAF preparation.
Brains of hamsters infected with the 263K scrapie strain were collected at the terminal stage of the disease (~80 days; titer of 2x10 9 , 50% lethal dose/ml) and pooled together to be used for SAF purification. PrP sc was purified using the BioRad TeSeE purification kit according to the manufacturer's instructions with one exception. Cellular DNA and RNA in the homogenate were digested prior to the PK step of the protocole. The BioRad purification was used to purify PrP sc to avoid too much compaction and facilitate subsequent digestion by PK. protocole (see Supplementary) . The GdnHCl method was not successful and the data is not shown in this paper.
Preparation of inocula
The two types of treated SAF solutions constituted the reactive medium in which the conversion process of hamster recombinant alpha-PrP (AllPrion) took place. This was carried out using thermal conditions as previously described 9 and two other in vitro conversion methods were also tested (see Supplementary Methods).
Histopathology
Formalin-fixed brains were embedded in paraffin and processed for histopathology and PrP immunocytochemistry as previously described 19 . The anti-PrP antibody used was SAF 32. Sections were analysed in double-blind fashion.
Nucleic acid analysis
One microliter of the solution was deposited in wells of a Lab-on-a-Chip device (2100 Bioanalyser, Small RNA Assay, and RNA 6000 Nano, Agilent Technologies) according to the manufacturer's recommendations.
Electron microcopy
Five microliters of the solution were deposited on grids and negatively stained as previously a, The order of inoculation was done randomly, excluding cross contamination; for example, the positive inoculum 8 followed the two negative inocula 6 and 7. b, Delay between injection and death/sacrifice at the time when the animal show severe clinical signs (ataxia, rachitism,tremor). c, All surviving animals were sacrified at 545 days post inoculation φ, Aberrant scrapie infection observed in one control animal that can be clearly attributed to enviromental contamination. The animal (death at 413 days) lived in a cage with three animals of another experimental group injected with contaminated inoculum from an unsuccessful PrP sc removal protocole involving GnHCl (data not shown). These animals died at 231, 247 and 372 days and it is known that feces and urine are very efficient sources of infectivity 20, 21 . This was confirmed by WB ( Supplementary Fig. 4b, lane 3) and histopathology giving a lesion profile identical to 263K (Supplementary Fig. 5 ). *, These animals died of causes other than scrapie disease showed no clinical signs and no PrP sc accumulation (some are shown in Supplementary Fig. 4b ). Injection into golden syrian hamsters. All samples were kept at 4°C until injection day (no longer than 3 days) and prepared for injection (diluted) on the day of the injection.
Samples were diluted to a final 'equivalent PrP sc ' of 4 ng/μl with either PBS or MOPS buffer depending on the buffer of the solution injected. Each hamster received a total of 50μl in the right hemisphere of the brain. Gloves were changed in between each inoculum to avoid contaminations. The order of injection was: inocula 1, 2, 7, 8, 6, 11, 12, 13.
For the second experiment, the injections were performed in the same way as in the first experiment.
